Financial Daily from THE HINDU group of publications
Thursday, Mar 30, 2006
Financial Daily from THE HINDU group of publications Thursday, Mar 30, 2006 |
|
|
|
|
|
|
|
Corporate
-
Research & Development Markets - Public Offer Opto Circuits fixes offer price at Rs 240-270 Our Bureau
Mumbai , March 29 The price band for the follow-on public offer of healthcare equipmentcompany Opto Circuits (India) Ltd has been fixed between Rs 240 and Rs 270. The company expects to raise Rs 108 crore to upgrade its research facility and fund working capital requirements. The issue, to be raised entirely through the book-building route, comprises 40 lakh shares at a face value of Rs 10 each. After the public issue, the promoter's holding will come down from 36 per cent to about 31 per cent, Mr Vinod Ramnani, Chairman and Managing Director, told Business Line. After having acquired German stent-maker EuroCor GmbH in December last year for Rs 60 crore, Mr Ramnani said the company was looking at organic and inorganic growth. Overseas acquisitions are part of the plan, he said. Meanwhile, EuroCor Life Sciences, a wholly owned subsidiary of Opto, has also received the regulatory CE approval for marketing and sale of its drug-eluting stent Taxcor. According to Mr Ramnani, the approval allows EuroCor to sell Taxcor globally, with the exception of the US and Japan. A large part of Opto Circuits' revenues of over Rs 122 crore is from the overseas market. But the company is looking to increase its focus in the domestic market as well, he said.
More Stories on : Research & Development | Public Offer | Medical & Surgical Equipments
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2006, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|